C4 Therapeutics, Inc.

NasdaqGS:CCCC Stock Report

Mkt Cap: US$400.0m

C4 Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure

CEO

Andrew Hirsch (51 yo)

2.25yrs

Tenure

US$952,200

Compensation

Mr. Andrew J. Hirsch is the President of C4 Therapeutics, Inc since September 14, 2020 and has been its Chief Executive Officer since October 2, 2020. Mr. Hirsch has been Director of C4 Therapeutics, Inc s...

CEO Compensation Analysis

How has Andrew Hirsch's remuneration changed compared to C4 Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$107m

Jun 30 2022n/an/a

-US$99m

Mar 31 2022n/an/a

-US$95m

Dec 31 2021US$952kUS$580k

-US$84m

Sep 30 2021n/an/a

-US$80m

Jun 30 2021n/an/a

-US$82m

Mar 31 2021n/an/a

-US$73m

Dec 31 2020US$21mUS$168k

-US$66m

Compensation vs Market: Andrew's total compensation ($USD952.20K) is below average for companies of similar size in the US market ($USD2.52M).

Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Hirsch
CEO, President & Director2.33yrsUS$952.20k0.038%
$ 153.8k
Kenneth Anderson
Co-Founderno dataUS$636.40k0.61%
$ 2.4m
Lauren White
Chief Financial Officer1.58yrsUS$4.24m0.0054%
$ 21.6k
Stewart Fisher
Chief Scientific Officer4.67yrsUS$3.79m0.15%
$ 604.9k
Jolie Siegel
Chief Legal Officer2.5yrsUS$3.38m0.0054%
$ 21.6k
Adam Crystal
Chief Medical Officer3.92yrsUS$3.56m0.036%
$ 144.2k
Nathanael Gray
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Kendra Adams
Senior Vice President of Communications & Investor Relations2.17yrsno datano data
Kelly Schick
Chief People Officer2yrsno data0.0054%
$ 21.6k
Isabel Chiu
Senior Vice President of Strategic Alliances & Business Development6.83yrsno datano data
Christopher Nasveschuk
Senior Vice President of Chemistry2yrsno datano data
Roy Pollock
Senior Vice President of Biological Sciences3.92yrsno datano data

2.4yrs

Average Tenure

51yo

Average Age

Experienced Management: CCCC's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Hirsch
CEO, President & Director2.25yrsUS$952.20k0.038%
$ 153.8k
Kenneth Anderson
Co-Founder7.08yrsUS$636.40k0.61%
$ 2.4m
Nathanael Gray
Co-Founder & Member of Scientific Advisory Board6.17yrsno datano data
Bruce Downey
Interim Chairman & Lead Independent Director7.08yrsUS$648.91k1.0%
$ 4.0m
Glenn Dubin
Independent Director1.83yrsUS$1.32m1.58%
$ 6.3m
Malcolm Salter
Independent Director7.08yrsUS$655.39k0.023%
$ 93.0k
Christopher Bowden
Member of Clinical Advisory Boardno datano datano data
Christopher Kirk
Member of Scientific Advisory Board6.17yrsno datano data
Ross Levine
Member of Scientific Advisory Board5.5yrsno datano data
Ryan Corcoran
Member of Scientific Advisory Board3.33yrsno datano data
Scott Armstrong
Member of Scientific Advisory Board5.5yrsno datano data
Utpal Koppikar
Independent Director0.83yrno datano data

5.5yrs

Average Tenure

61yo

Average Age

Experienced Board: CCCC's board of directors are considered experienced (5.5 years average tenure).